Zai Lab Future Growth
Future criteria checks 5/6
Zai Lab is forecast to grow earnings and revenue by 68.2% and 34.2% per annum respectively. EPS is expected to grow by 66.6% per annum. Return on equity is forecast to be -12% in 3 years.
Key information
68.2%
Earnings growth rate
66.6%
EPS growth rate
Biotechs earnings growth | 27.6% |
Revenue growth rate | 34.2% |
Future return on equity | -12.0% |
Analyst coverage | Good |
Last updated | 18 Dec 2024 |
Recent future growth updates
Recent updates
The Zai Lab Limited (NASDAQ:ZLAB) Third-Quarter Results Are Out And Analysts Have Published New Forecasts
Nov 15Zai Lab Limited (NASDAQ:ZLAB) Stock Catapults 26% Though Its Price And Business Still Lag The Industry
Sep 28Zai Lab (NASDAQ:ZLAB) Has Debt But No Earnings; Should You Worry?
Sep 23Shareholders May Not Be So Generous With Zai Lab Limited's (NASDAQ:ZLAB) CEO Compensation And Here's Why
Jun 12Improved Revenues Required Before Zai Lab Limited (NASDAQ:ZLAB) Stock's 50% Jump Looks Justified
May 14A Risky Bet: Zai Lab's Uncertain Future
Apr 16Lacklustre Performance Is Driving Zai Lab Limited's (NASDAQ:ZLAB) 29% Price Drop
Mar 29We're Hopeful That Zai Lab (NASDAQ:ZLAB) Will Use Its Cash Wisely
Mar 24Why Investors Shouldn't Be Surprised By Zai Lab Limited's (NASDAQ:ZLAB) Low P/S
Jan 18Here's Why We're Not Too Worried About Zai Lab's (NASDAQ:ZLAB) Cash Burn Situation
Sep 22Zai Lab Limited's (NASDAQ:ZLAB) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Jun 24We Think Zai Lab (NASDAQ:ZLAB) Can Afford To Drive Business Growth
Jun 02Is Zai Lab Limited (NASDAQ:ZLAB) Trading At A 44% Discount?
Feb 16Zai Lab (NASDAQ:ZLAB) Is In A Good Position To Deliver On Growth Plans
Jan 20Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 930 | 75 | 32 | 132 | 11 |
12/31/2025 | 586 | -170 | -204 | -136 | 14 |
12/31/2024 | 393 | -267 | -162 | -229 | 13 |
9/30/2024 | 356 | -271 | -219 | -174 | N/A |
6/30/2024 | 323 | -298 | -215 | -202 | N/A |
3/31/2024 | 291 | -339 | -223 | -219 | N/A |
12/31/2023 | 267 | -335 | -193 | -198 | N/A |
9/30/2023 | 263 | -301 | -291 | -293 | N/A |
6/30/2023 | 252 | -393 | -371 | -364 | N/A |
3/31/2023 | 231 | -410 | -368 | -350 | N/A |
12/31/2022 | 215 | -443 | -393 | -368 | N/A |
9/30/2022 | 197 | -593 | -438 | -411 | N/A |
6/30/2022 | 182 | -529 | -472 | -446 | N/A |
3/31/2022 | 171 | -554 | -494 | -467 | N/A |
12/31/2021 | 144 | -704 | -568 | -549 | N/A |
9/30/2021 | 115 | -569 | -458 | -441 | N/A |
6/30/2021 | 87 | -537 | -374 | -359 | N/A |
3/31/2021 | 61 | -454 | -357 | -346 | N/A |
12/31/2020 | 49 | -269 | -227 | -216 | N/A |
9/30/2020 | 39 | -239 | -219 | -212 | N/A |
6/30/2020 | 29 | -240 | -212 | -200 | N/A |
3/31/2020 | 19 | -201 | -203 | -189 | N/A |
12/31/2019 | 13 | -195 | -206 | -191 | N/A |
9/30/2019 | 8 | -212 | -209 | -196 | N/A |
6/30/2019 | 4 | -181 | N/A | N/A | N/A |
3/31/2019 | 2 | -160 | N/A | N/A | N/A |
12/31/2018 | 0 | -139 | -108 | -98 | N/A |
9/30/2018 | N/A | -89 | N/A | N/A | N/A |
6/30/2018 | N/A | -67 | N/A | N/A | N/A |
3/31/2018 | N/A | -59 | N/A | N/A | N/A |
12/31/2017 | N/A | -50 | N/A | -32 | N/A |
9/30/2017 | N/A | -50 | N/A | N/A | N/A |
6/30/2017 | N/A | -50 | N/A | -41 | N/A |
3/31/2017 | N/A | -44 | N/A | -37 | N/A |
12/31/2016 | N/A | -38 | N/A | -32 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ZLAB is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: ZLAB is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ZLAB is expected to become profitable in the next 3 years.
Revenue vs Market: ZLAB's revenue (34.2% per year) is forecast to grow faster than the US market (9.1% per year).
High Growth Revenue: ZLAB's revenue (34.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ZLAB is forecast to be unprofitable in 3 years.
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 00:08 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Zai Lab Limited is covered by 28 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Michael Meng | BOCI Research Ltd. |
Linda Lu | BOCI Research Ltd. |
Wai Chak Yuen | BOCI Research Ltd. |